[96a5a0]: / output / allTrials / logical / NCT02830282_logical.json

Download this file

509 lines (509 with data), 25.0 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
{
"info": {
"nct_id": "NCT02830282",
"official_title": "Surveillance Markers of Utility for Recurrence After Neoadjuvant Chemotherapy for Breast Cancer",
"inclusion_criteria": "* Enrollment on the treatment phase of the I-SPY 2 TRIAL\n* Completed a standard neoadjuvant chemotherapy regimen or assigned treatment on I-SPY 2 and planning definitive surgical resection. Participants who have discontinued assigned treatment on I-SPY 2, switched to standard of care, and have completed a standard neoadjuvant chemotherapy regimen are still considered eligible.\n* Pre-surgical imaging or clinical examination demonstrating residual disease in the breast. Participants with any extent of enhancement attributable to tumor on the pre-surgical MRI are eligible. No minimum extent of palpable tumor pre-surgery is required.\n* Willing to undergo bone marrow aspiration and blood specimen collection per protocol specifications\n* No clinical evidence of distant metastatic disease. Pre-chemotherapy staging scans are sufficient in the absence of any symptoms or subsequent clinical evidence suggesting distant metastases\n* Age 18 or over and are able to give informed consent\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Individuals under the age of 18\n* Individuals who cannot understand and give informed consent. We will not be assessing decisional capacity; determination of ability to give informed consent will be at the discretion of the treating physician.\n* Pregnancy. Participants in the parent I-SPY 2 TRIAL are screened for pregnancy at enrollment and pregnancy is an exclusion criteria. No additional screening for pregnancy is required for participants enrolling on SURMOUNT. However if a study participant does become pregnant while on study or during the course of the 10 year follow-up, the study participant will remain on the study protocol and will not be withdrawn. Because this is an observational study and does not have a therapeutic component, there will be no increased risk to following a study participant through annual blood draws and medical information abstraction from the medical chart who may or may not become pregnant during the course of the follow-up period.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "* Enrollment on the treatment phase of the I-SPY 2 TRIAL",
"criterions": [
{
"exact_snippets": "Enrollment on the treatment phase of the I-SPY 2 TRIAL",
"criterion": "enrollment on treatment phase",
"requirement": {
"requirement_type": "trial",
"expected_value": "I-SPY 2 TRIAL"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Enrollment on the treatment phase of the I-SPY 2 TRIAL",
"criterion": "enrollment on treatment phase",
"requirement": {
"requirement_type": "trial",
"expected_value": "I-SPY 2 TRIAL"
}
}
]
}
},
{
"identified_line": {
"line": "* Completed a standard neoadjuvant chemotherapy regimen or assigned treatment on I-SPY 2 and planning definitive surgical resection. Participants who have discontinued assigned treatment on I-SPY 2, switched to standard of care, and have completed a standard neoadjuvant chemotherapy regimen are still considered eligible.",
"criterions": [
{
"exact_snippets": "Completed a standard neoadjuvant chemotherapy regimen",
"criterion": "neoadjuvant chemotherapy regimen",
"requirement": {
"requirement_type": "completion",
"expected_value": true
}
},
{
"exact_snippets": "assigned treatment on I-SPY 2",
"criterion": "I-SPY 2 treatment",
"requirement": {
"requirement_type": "assignment",
"expected_value": true
}
},
{
"exact_snippets": "planning definitive surgical resection",
"criterion": "definitive surgical resection",
"requirement": {
"requirement_type": "planning",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Completed a standard neoadjuvant chemotherapy regimen",
"criterion": "neoadjuvant chemotherapy regimen",
"requirement": {
"requirement_type": "completion",
"expected_value": true
}
},
{
"exact_snippets": "assigned treatment on I-SPY 2",
"criterion": "I-SPY 2 treatment",
"requirement": {
"requirement_type": "assignment",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Completed a standard neoadjuvant chemotherapy regimen",
"criterion": "neoadjuvant chemotherapy regimen",
"requirement": {
"requirement_type": "completion",
"expected_value": true
}
},
{
"exact_snippets": "assigned treatment on I-SPY 2",
"criterion": "I-SPY 2 treatment",
"requirement": {
"requirement_type": "assignment",
"expected_value": false
}
}
]
}
]
},
{
"exact_snippets": "planning definitive surgical resection",
"criterion": "definitive surgical resection",
"requirement": {
"requirement_type": "planning",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Pre-surgical imaging or clinical examination demonstrating residual disease in the breast. Participants with any extent of enhancement attributable to tumor on the pre-surgical MRI are eligible. No minimum extent of palpable tumor pre-surgery is required.",
"criterions": [
{
"exact_snippets": "Pre-surgical imaging or clinical examination demonstrating residual disease in the breast.",
"criterion": "residual disease in the breast",
"requirement": {
"requirement_type": "demonstration",
"expected_value": true
}
},
{
"exact_snippets": "Participants with any extent of enhancement attributable to tumor on the pre-surgical MRI are eligible.",
"criterion": "enhancement attributable to tumor on the pre-surgical MRI",
"requirement": {
"requirement_type": "extent",
"expected_value": "any"
}
},
{
"exact_snippets": "No minimum extent of palpable tumor pre-surgery is required.",
"criterion": "palpable tumor pre-surgery",
"requirement": {
"requirement_type": "minimum extent",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Pre-surgical imaging or clinical examination demonstrating residual disease in the breast.",
"criterion": "residual disease in the breast",
"requirement": {
"requirement_type": "demonstration",
"expected_value": true
}
},
{
"exact_snippets": "Participants with any extent of enhancement attributable to tumor on the pre-surgical MRI are eligible.",
"criterion": "enhancement attributable to tumor on the pre-surgical MRI",
"requirement": {
"requirement_type": "extent",
"expected_value": "any"
}
}
]
},
{
"exact_snippets": "No minimum extent of palpable tumor pre-surgery is required.",
"criterion": "palpable tumor pre-surgery",
"requirement": {
"requirement_type": "minimum extent",
"expected_value": false
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Willing to undergo bone marrow aspiration and blood specimen collection per protocol specifications",
"criterions": [
{
"exact_snippets": "Willing to undergo bone marrow aspiration",
"criterion": "bone marrow aspiration",
"requirement": {
"requirement_type": "willingness",
"expected_value": true
}
},
{
"exact_snippets": "Willing to undergo ... blood specimen collection",
"criterion": "blood specimen collection",
"requirement": {
"requirement_type": "willingness",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Willing to undergo bone marrow aspiration",
"criterion": "bone marrow aspiration",
"requirement": {
"requirement_type": "willingness",
"expected_value": true
}
},
{
"exact_snippets": "Willing to undergo ... blood specimen collection",
"criterion": "blood specimen collection",
"requirement": {
"requirement_type": "willingness",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* No clinical evidence of distant metastatic disease. Pre-chemotherapy staging scans are sufficient in the absence of any symptoms or subsequent clinical evidence suggesting distant metastases",
"criterions": [
{
"exact_snippets": "No clinical evidence of distant metastatic disease",
"criterion": "distant metastatic disease",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"condition": {
"exact_snippets": "Pre-chemotherapy staging scans are sufficient in the absence of any symptoms or subsequent clinical evidence suggesting distant metastases",
"criterion": "symptoms or subsequent clinical evidence suggesting distant metastases",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
"then_criteria": {
"exact_snippets": "No clinical evidence of distant metastatic disease",
"criterion": "distant metastatic disease",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "* Age 18 or over and are able to give informed consent",
"criterions": [
{
"exact_snippets": "Age 18 or over",
"criterion": "age",
"requirement": {
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
},
{
"exact_snippets": "able to give informed consent",
"criterion": "ability to give informed consent",
"requirement": {
"requirement_type": "ability",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Age 18 or over",
"criterion": "age",
"requirement": {
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
},
{
"exact_snippets": "able to give informed consent",
"criterion": "ability to give informed consent",
"requirement": {
"requirement_type": "ability",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirement": {
"requirement_type": "expected_value",
"expected_value": "female"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirement": {
"requirement_type": "expected_value",
"expected_value": "female"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Individuals under the age of 18",
"criterions": [
{
"exact_snippets": "under the age of 18",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<",
"value": 18,
"unit": "years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "under the age of 18",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<",
"value": 18,
"unit": "years"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Individuals who cannot understand and give informed consent. We will not be assessing decisional capacity; determination of ability to give informed consent will be at the discretion of the treating physician.",
"criterions": [
{
"exact_snippets": "cannot understand and give informed consent",
"criterion": "ability to give informed consent",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "cannot understand and give informed consent",
"criterion": "ability to give informed consent",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [
{
"identified_line": {
"line": "* Pregnancy. Participants in the parent I-SPY 2 TRIAL are screened for pregnancy at enrollment and pregnancy is an exclusion criteria. No additional screening for pregnancy is required for participants enrolling on SURMOUNT. However if a study participant does become pregnant while on study or during the course of the 10 year follow-up, the study participant will remain on the study protocol and will not be withdrawn. Because this is an observational study and does not have a therapeutic component, there will be no increased risk to following a study participant through annual blood draws and medical information abstraction from the medical chart who may or may not become pregnant during the course of the follow-up period.",
"criterions": [
{
"exact_snippets": "screened for pregnancy at enrollment",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "screening",
"expected_value": true
}
},
{
"exact_snippets": "pregnancy is an exclusion criteria",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "exclusion",
"expected_value": true
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
}
],
"failed_miscellaneous": []
}